skip to Global Navigation Bar skip to main content


homeHome > About Us > Press Release > News

News

News Content
Daewoong Pharmaceuticals expands entry to new markets with license in Mexico and India on Nabota
Date 2016-09-22 Hit 15354
list
News List
Prev Daewoong Pharmaceuticals disseminates the excellence of ‘Nabota’ in IMCAS
Next Daewoong Pharmaceutical presents its research results on ‘treatments for fibrosis and autoimmune disease’ at ACR